SHYNEQURIA WILLIAMS-MCNEALY: Open Payments
NPI 1104099399 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 12 payments from 7 companies in 2025. Trend: 2023 $295 · 2024 $208 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| ABBVIE INC. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ViiV Healthcare Company | 1 | $19 |
| Alkermes, Inc. | 1 | $15 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, REXULTI, AUSTEDO XR, DOVATO, LYBALVI.
Industry payments across FL — which companies pay providers there.
